Targeting the NLRP3 inflammasome-IL-1beta pathway in type 2 diabetes and obesity. Meier DT, de Paula Souza J, Donath MY. Diabetologia 2024 Nov 4. doi: 10.1007/s00125-024-06306.

Read + Share

Amedeo Smart

Independent Medical Education

Meier DT, de Paula Souza J, Donath MY. Targeting the NLRP3 inflammasome-IL-1beta pathway in type 2 diabetes and obesity. Diabetologia 2024 Nov 4. doi: 10.1007/s00125-024-06306.
PMID: 39496966